Identifier |
Protein names |
Gene names |
Cross reference refseq |
Length |
Species |
Q5D0K2
|
Cholecystokinin receptor type A; CCK-A receptor; CCK-AR; Cholecystokinin-1 receptor; CCK1-R;
|
CCKAR;
|
NP_001012664.1;
|
428
|
dog
|
Q9TS44
|
Cholecystokinins; CCK; [Cleaved into: Cholecystokinin-58 (CCK58); Cholecystokinin-58 desnonopeptide ((1-49)-CCK58); Cholecystokinin-39 (CCK39); Cholecystokinin-33 (CCK33); Cholecystokinin-25 (CCK25); Cholecystokinin-18 (CCK18); Cholecystokinin-12 (CCK12);癷?癸
|
CCK;
|
NULL
|
58
|
dog
|
Q68Y88
|
C-C motif chemokine 13; Monocyte chemoattractant protein 4; Monocyte chemotactic protein 4; MCP-4; Small-inducible cytokine A13;
|
CCL13;
|
NP_001003966.1;
|
98
|
dog
|
Q95N01
|
C-C motif chemokine 17; CC chemokine TARC; Small-inducible cytokine A17; Thymus and activation-regulated chemokine;
|
CCL17; TARC;
|
NP_001003051.1;XP_005617272.1;
|
99
|
dog
|
Q68Y86
|
C-C motif chemokine 24; Eosinophil chemotactic protein 2; Eotaxin-2; Small-inducible cytokine A24;
|
CCL24;
|
NP_001003967.1;
|
119
|
dog
|
Q68A93
|
C-C motif chemokine 25; Small-inducible cytokine A25;
|
CCL25;
|
NP_001005259.1;XP_005632371.1;XP_005632372.1;
|
151
|
dog
|
Q64H35
|
C-C motif chemokine 26; Eotaxin-3; Small-inducible cytokine A26;
|
CCL26;
|
NP_001005253.1;
|
94
|
dog
|
Q68A91
|
C-C motif chemokine 28; Small-inducible cytokine A28;
|
CCL28; SCYA28;
|
NP_001005257.1;
|
128
|
dog
|
P52203
|
C-C motif chemokine 2; Monocyte chemoattractant protein 1; Monocyte chemotactic protein 1; MCP-1; Small-inducible cytokine A2;
|
CCL2; MCP1 SCYA2;
|
NP_001003297.1;
|
101
|
dog
|
Q68A92
|
C-C motif chemokine 3; Small-inducible cytokine A3;
|
CCL3;
|
NP_001005251.1;
|
92
|
dog
|
Q68AZ0
|
C-C motif chemokine 4; Small-inducible cytokine A4;
|
CCL4; SCYA4;
|
NP_001005250.1;
|
92
|
dog
|
Q8HYS0
|
C-C motif chemokine 5; Small-inducible cytokine A5; T-cell-specific protein RANTES;
|
CCL5; SCYA5;
|
NP_001003010.1;
|
91
|
dog
|
Q68AY9
|
C-C motif chemokine 8; Monocyte chemoattractant protein 2; Monocyte chemotactic protein 2; MCP-2; Small-inducible cytokine A8;
|
CCL8; MCP2;
|
NP_001005255.1;
|
99
|
dog
|
Q659K0
|
G2/mitotic-specific cyclin-B3;
|
CCNB3;
|
NP_001005763.1;
|
1330
|
dog
|
Q64HP0
|
G1/S-specific cyclin-D1;
|
CCND1;
|
NP_001005757.1;
|
295
|
dog
|
Q64H34
|
C-C chemokine receptor type 3; C-C CKR-3; CC-CKR-3; CCR-3; CCR3; CKR3; CD antigen CD193;
|
CCR3; CMKBR3;
|
NP_001005261.1;XP_005632374.1;
|
359
|
dog
|
Q8MJW8
|
C-C chemokine receptor type 4; C-C CKR-4; CC-CKR-4; CCR-4; CCR4; CD antigen CD194;
|
CCR4;
|
NP_001003020.1;XP_005634207.1;
|
360
|
dog
|
Q5ECR9
|
C-C chemokine receptor type 5; C-C CKR-5; CC-CKR-5; CCR-5; CCR5; CD antigen CD195;
|
CCR5; CMKBR5;
|
NP_001012342.2;XP_005632385.1;
|
352
|
dog
|
O46634
|
CD166 antigen; Activated leukocyte cell adhesion molecule; SB-10 antigen; CD antigen CD166; Fragment;
|
ALCAM;
|
NULL
|
521
|
dog
|
Q3C2E2
|
B-lymphocyte antigen CD20; Membrane-spanning 4-domains subfamily A member 1; CD antigen CD20;
|
MS4A1; CD20;
|
NP_001041493.1;
|
297
|
dog
|